47
Participants
Start Date
July 1, 2019
Primary Completion Date
December 18, 2020
Study Completion Date
December 18, 2020
chiauranib
in the phase of pilot trial, 25mg orally once daily; in the formal phase, 50mg orally once daily
etoposide
50mg orally once daily for 21 days, 7 days off, every 28 days for a cycle, 6 cycles at most
paclitaxel
60mg/m2, i.v infusion on day 1, 8 and 15, every 21 days for a cycle, 6 cycles at most
Fudan University Shanghai Cancer Center, Shanghai
Lead Sponsor
Chipscreen Biosciences, Ltd.
INDUSTRY